The laboratory of hypercoagulability: A review of present-day techniques

Journal of Thrombosis and Thrombolysis

Volumn 5, Issue 3, 1998, Pages 269-276

  Khan, Fauzia ^a   Pechet, Liberto ^a   Snyder, L Michael ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Coagulation; Hypercoagulability; Thrombophilia; Thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; HEPARIN; HOMOCYSTEINE; PLASMINOGEN; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBOMODULIN; VON WILLEBRAND FACTOR; WARFARIN;

ACTIVATED PROTEIN C RESISTANCE; ANTICOAGULANT THERAPY; ANTITHROMBIN III DEFICIENCY; BLOOD CLOTTING DISORDER; DISSEMINATED INTRAVASCULAR CLOTTING; HUMAN; HYPERCOAGULABILITY; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; REVIEW; THROMBOPHILIA;

EID: 0031777145     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008856228577     Document Type: Review

References (32)

1. Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia: Part I. Thromb Haemost 1996;76:651-662.
2. Egeberg O. Inherited antithrombin deficiency causing thrombophillia. Thromb Diath Haem 1965;13:516-530.
3. Griffin JH, Evatt B, Zimmerman T, Kleiss A, et al. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981;68:1370-1373.
4. Comp PC, Esmon C. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 1984;311:1525-1528.
5. Dahlback B, Carlssson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004-1008.
6. Bombelli T, Mueller M, Haeberli A. Anticoagulant properties of the vascular endothelium. Thromb Haemost 1997;77:408-423.
7. Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia: Part II. Thromb Haemost 1996;76:824-834.
8. De Stefano V, Finazzi G, Mannuci P M. Inherited thrombophilia: Pathogenesis, clinical syndromes, and management. Blood 1996;87:3531-3544.
9. Khan F, Snyder LM, Pechet L. The laboratory of coagulation Jl Thromb Thrombolys 1998;5:83-88.
10. Rodeghiero F, Tosetto A. The VITA project: Populationbased distributions of protein C, antithrombin III, heparincofactor II and plasminogen - relationship with physiological variables and establishment of reference ranges. Thromb Haemost 1996;76:226-233.
11. Conlan MG, Folsom AR, Finch A, et al. Antithrombin III: Association with age, race, sex and cardiovscular disease risk factors. Thromb Haemost 1994;72:551-556.
12. van Boven HH, Lane DA. Antithrombin and its inherited deficiency states. Semin Hematol 1997;34:188-204.
13. Blajchman MA, Austin RC, Fernandex-Rachubinski F, Sheffield WP. Molecular basis of inherited human antithrombin deficiency. Blood 1992;80:2159-2171.
14. van Voorthuizen H, Kluft C. Improved assay conditions for automated antithrombin III determination with the chromogenic substrates-2238. Thromb Haemost 1984:52:350-353.
15. Henkens CMA, Bom VJJ, van der Schaaf, et al. Plasma levels of protein S, protein C, and factor X: Effects of sex, hormonal state and age. Thromb Haemost 1995;74:1271-1275.
16. Manucci PM, Boyer C, Tripodi A. Multicenter comparison of five functional and two immunological assays for protein C. Thromb Haemost 1987;57:44-48.
17. Gandrille S, Borgel D, Ireland H, et al. Protein S deficiency: A database of mutations. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1997;77:1201-1214.
18. Malm J, Laurell M, Dahlback B. Changes in the plasma levels of vitamin K-dependent proteins C and S and of C4b-binding protein during pregnancy and oral contraception. Br J Haematol. 1988;68:437-443.
19. Triposi A, Bertina RM. Multicenter evaluation of three commercial methods for measuring protein S antigen. Thromb Haemost 1992;68:149-154.
20. Svensson JP, Zoller B, Dahlback B. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls. Thromb Haemost 1996;77:332-335.
21. Den Heijer Martin, Koster Ted, Blom Henk. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;334:759-762.
22. Nygard O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;373:230-236.
23. Mendel H, Brenner B, Berant M, et al. Coexistence of hereditary homocysteinenuria and factor V Leiden - effect on thrombosis. N Engl J Med. 1996;334:763-768.
24. Carmel R, Green R, Cook J. Red cells: Folate, cobalamine, homocysteine, and iron - anemias and other issues. Education Program American Society of Hematology, 1994:1-9.
25. Stampfer MJ, Malinow MR, Willet WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992;268:709-715.
26. Poort SR, Rosendal PH, Bertina R, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin and an increase in venous thrombosis. Blood 1996;88:3698-3703.
27. Tait RC, Walker ID, Conkie JA, Islam SIAM, McCall F. Isolated familial plasminogen deficiency may not be a risk factor for thrombosis. Thromb Haemost 1996;76:1004-1008.
28. Park CT, Creasey AA, Wright SD. Tissue factor pathway inhibitor blocks cellular effects of endotoxin by binding to endotoxin and interfering with transfer to CD14. Blood 1997;89:4268-4274.
29. Kessler Craig M, Tang Zhao Cheng, Jacobs Helen M, et al. The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus induced disseminated intravascular coagulation in guinea pigs: Substantial reduction in mortality and morbidity. Blood 1997;89:4393-4401.
30. Bick RL. Disseminated intravascular coagulation. Clin Lab Med 1994;14:729-768.
31. Galli M, Finazzi G, Barbui T. Antiphospholipid antibodies: Predictive value of laboratory tests. Thromb Haemost 1997;71:75-78.
32. Moll S, Ortel LT. Monitoring warfarin therapy in patients with lupus anticoagulant. Ann Intern Med 1997;127:177-185.